Solid Tumor Working Group

• AMC-111

  Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living with HIV: A Feasibility Study

• AMC-095

  A Phase I Study of Ipilimumab and Nivolumab in Advanced HIV-Associated Solid Tumors, with Expansion Cohorts in HIV-Associated Solid Tumors and a Cohort of HIV-Associated Classical Hodgkin Lymphoma

• AMC-087

  Phase I Trial of Cabozantinib (XL184) for Advanced Solid Tumors in Persons with HIV Infection

Human Papillomavirus Working Group

• AMC-099

  HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV (COVENANT)

• AMC-A01

  Anal Cancer/HSIL Outcomes Research (ANCHOR) Study

• AMC-103

  A Phase 2 Evaluation of VGX-3100, a Synthetic DNA Immunotherapy Targeting Human Papillomavirus 16 and 18 E6 and E7 Proteins, for Anal High-Grade Squamous Intraepithelial Lesions (HSIL) in HIV-Positive Individuals

• AMC-092

  A multicenter observational and feasibility study of excision of superficially invasive squamous cell carcinoma (SISCCA) of the anal canal and perianus in HIV-infected persons

• AMC-088

  A Randomized Phase III Study of Intra-anal Imiquimod 2.5% vs. Topical 5-Fluorouracil 5% vs. Observation for the Treatment of High-grade Squamous Anal Intraepithelial Lesions (HSIL) in HIV-infected Men and Women

Kaposi's Sarcoma Working Group

• AMC-S007

  Longitudinal Quality of Life Study Among Participants with AIDS-Associated Kaposi Sarcoma at Bugando Medical Centre, in Mwanza, Tanzania

• AMC-098

  A Pilot Study of Nelfinavir for the Treatment of Kaposi Sarcoma

• AMC-096

  A Phase II Study of sEphB4-HSA in Kaposi Sarcoma

Hematologic Malignancy Working Group

• AMC-097

  A Phase I Study of Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-Selected CD34+ Cells

• AMC-101

  Phase I and Dose-Expansion Study of Ibrutinib and R-da-EPOCH for Front Line Treatment of AIDS-Related Lymphomas

• AMC-105

  A Multicenter, Open-label Feasibility Study of Daratumumab with Dose-Adjusted EPOCH in Newly Diagnosed Plasmablastic Lymphoma

• AMC-S004

  Clinical and Genomic Factors for Prognosis of Primary Effusion Lymphoma

Translational

• AMC-083

  Tissue Acquisition for Analysis of Prognostic Factors, Immunology, and Genetic Progression of HIV-1 Associated Malignancies